Invention Grant
- Patent Title: Polyomavirus neutralizing antibodies
-
Application No.: US15758491Application Date: 2016-09-08
-
Publication No.: US10450366B2Publication Date: 2019-10-22
- Inventor: Johanna Abend , Zorica Dragic , Adam Lloyd Feire , Mark Knapp , Steven Kovacs , Elisabetta Traggiai , Lichun Wang , Yongqiang Wang , Danqing Wu , Qilong Wu , Fangmin Xu
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Mark H. Hopkins
- Priority: WOPCT/CN2015/089764 20150916
- International Application: PCT/IB2016/055339 WO 20160908
- International Announcement: WO2017/046676 WO 20170323
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/42 ; C07K16/00 ; C07K16/08 ; A61K45/06 ; A61K9/19
Abstract:
The present disclosure is directed to anti-VP1 antibodies, antibody fragments, and their uses for the reducing the likelihood or treatment of polyoma virus infection.
Public/Granted literature
- US20190002533A1 POLYOMAVIRUS NEUTRALIZING ANTIBODIES Public/Granted day:2019-01-03
Information query
